Clinical RoundupFree Traditional prostate cancer risk factors do not predict hormone therapy benefit, UCLA-led study finds August 14, 2026Vol.52 No.32
Clinical RoundupFree Half of prostate cancer focal therapy use falls outside current guideline-supported patient groups, study finds August 14, 2026Vol.52 No.32
Clinical RoundupFree HCC-LIVE consortium publishes treatment framework for hepatocellular carcinoma August 14, 2026Vol.52 No.32
Clinical RoundupFree Baylor researchers develop drug aimed at overcoming cancer drug resistance August 14, 2026Vol.52 No.32
Clinical RoundupFree SANRECO phase II study of divesiran in polycythemia vera meets primary endpoint August 14, 2026Vol.52 No.32
Clinical Roundup Phase III XPORT-EC-042 trial in endometrial cancer does not meet primary endpoint August 07, 2026Vol.52 No.31
Clinical Roundup BRCA-negative patients may still be high-risk for breast cancer, study finds August 07, 2026Vol.52 No.31
Clinical Roundup DELFI liquid biopsy detects liver cancer across diverse international populations, Hopkins-led study finds August 07, 2026Vol.52 No.31
Clinical Roundup Mesothelioma cells rewire genes to resist GNE-7883, study finds August 07, 2026Vol.52 No.31
Clinical Roundup Biobank of tumor models reveals cancers’ weak spots, Nature study finds August 07, 2026Vol.52 No.31
